Greece vs Timor-Leste: Access to anti-retroviral drugs, female
Greece
57.0%
in 2024
Timor-Leste
57.0%
in 2024
Greece rank
108th
Timor-Leste rank
108th
Access to anti-retroviral drugs, female over time
- Greece
- Timor-Leste
How they compare
Greece currently reports 57.0% against 57.0% in Timor-Leste, a difference of 0.0%.
The two have swapped places 1 time across 23 shared years of data; in 2000 it was Greece ahead.
Greece ranks 108th and Timor-Leste ranks 108th of 141 countries.
Greece has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Greece | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.6% | 1.6% | 43.0% | Greece |
| 2010s | 49.7% | 22.1% | 27.6% | Greece |
| 2020s | 55.6% | 49.0% | 6.6% | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Greece or Timor-Leste?
- Greece, at 57.0% against 57.0% in Timor-Leste as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Greece and Timor-Leste?
- 0.0%, with Greece ahead.
- How many years of comparable data are there for Greece and Timor-Leste?
- 23 years are reported by both, from 2000 to 2024.
- How do Greece and Timor-Leste rank globally for access to anti-retroviral drugs, female?
- Greece ranks 108th and Timor-Leste ranks 108th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.